Expression of miR-148a in Human Meningioma Tumors

Document Type : Original Article(s)

Authors

1 Pediatrics Inherited Diseases Research Center AND Research Institute for Primordial Prevention of Non-communicable Diseases AND Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Assistant Professor, Pediatric Inherited Diseases Research Center, Research Institute for Primordial Prevention of Non-communicable Disease AND Department of Genetics and Molecular Biology, School of Medicine, Isfahan University Of Medical Sciences, Isfahan, Iran

Abstract

Background: Meningioma is one of the most prevalent brain tumors and is derived from meninges. Although, the tumor is usually benign and has limited numbers of genetic aberrations, but intracranial location often cause serious and lethal outcomes. Following role of phosphatase and tensin homolog (PTEN) protein, a tumor suppressor gene that is one of miR-148a targets in meningioma and as the microRNA has showed up regulation in brain tumor samples in microarray data, we assessed miR-148a expression pattern in meningioma.Methods: We evaluated miR-148a expression among 25 meningioma and 4 normal tissues using real-time polymerase chain reaction method.Findings: The expression level of miR-148a showed significant difference between meningioma and normal tissues (P < 0.05).Conclusion: As a result, since there is a significance difference in the miR-148a expression in meningioma tumors compared to normal tissues, the microRNA might be considered as a marker in meningiomas tumors, with further investigations.

Keywords

References

  1. Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol 2010; 99(3): 307-14.
  2. Raizer J. Meningiomas. Curr Treat Options Neurol 2010; 12(4): 360-8.
  3. Zhi F, Zhou G, Wang S, Shi Y, Peng Y, Shao N, et al. A microRNA expression signature predicts meningioma recurrence. Int J Cancer 2013; 132(1): 128-36.
  4. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136(2): 215-33.
  5. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116(2): 281-97.
  6. Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol 2007; 23: 175-205.
  7. Mu P, Han YC, Betel D, Yao E, Squatrito M, Ogrodowski P, et al. Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev 2009; 23(24): 2806-11.
  8. Yuan K, Lian Z, Sun B, Clayton MM, Ng IOL, Feitelson MA. Abstract C16: miR-148a regulates the expression of PTEN in hepatitis B associated hepatocellular carcinoma. Cancer Research 2011; 71(18 Suppl): C16.
  9. Peters N, Wellenreuther R, Rollbrocker B, Hayashi Y, Meyer-Puttlitz B, Duerr EM, et al. Analysis of the PTEN gene in human meningiomas. Neuropathol Appl Neurobiol 1998; 24(1): 3-8.
  10. Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 2010; 28(10): 1721-6.
  11. Brenner WG, Romanov GA, Kollmer I, Burkle L, Schmulling T. Immediate-early and delayed cytokinin response genes of Arabidopsis thaliana identified by genome-wide expression profiling reveal novel cytokinin-sensitive processes and suggest cytokinin action through transcriptional cascades. Plant J 2005; 44(2): 314-33.
  12. Becanovic K, Pouladi MA, Lim RS, Kuhn A, Pavlidis P, Luthi-Carter R, et al. Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis. Hum Mol Genet 2010; 19(8): 1438-52.
  13. Roth P, Wischhusen J, Happold C, Chandran PA, Hofer S, Eisele G, et al. A specific miRNA signature in the peripheral blood of glioblastoma patients. J Neurochem 2011; 118(3): 449-57.
  14. Liu TP, Zeng Y. Large time behavior of solutions for general quasilinear hyperbolic-parabolic systems of conservation laws (Memoirs of the American Mathematical Society). Providence, RI: American Mathematical Society; 1997.
  15. Srinivasan S, Patric IR, Somasundaram K. A ten-microRNA expression signature predicts survival in glioblastoma. PLoS One 2011; 6(3): e17438.
  16. Chen Y, Song Y, Wang Z, Yue Z, Xu H, Xing C, et al. Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg 2010; 14(7): 1170-9.
  17. Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, et al. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 2009; 23(11): 1327-37.
  18. Rao SA, Santosh V, Somasundaram K. Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Mod Pathol 2010; 23(10): 1404-17.
  19. Joachim T, Ram Z, Rappaport ZH, Simon M, Schramm J, Wiestler OD, et al. Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation-induced human meningiomas. Int J Cancer 2001; 94(2): 218-21.
Journal of Isfahan Medical School
Volume 33, Issue 325 - Serial Number 325
January and February 2015
Pages 252-257

Files

History

  • Receive Date: 04 April 2015
  • Revise Date: 23 May 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics